Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the syphilis immunoassay diagnostics market size evolved in recent years?
In recent times, the market size for syphilis immunoassay diagnostics has seen a substantial expansion. The market, which was valued at $31.25 billion in 2024, is projected to grow to $33.76 billion by 2025 with a compound annual growth rate (CAGR) of 8.0%. This growth during the historical period is linked to an increase in certain socioeconomic factors. These include a rise in sexually transmitted diseases (STDs), an increased rate of unreported instances of sexual activity, a growing occurrence of fatal syphilis diseases, the implementation of new initiatives by the government, as well as an increased focus on early disease detection.
What are the predictions for the syphilis immunoassay diagnostics market size in the coming years?
The syphilis immunoassay diagnostics market size is expected to see strong growth in the next few years. It will grow to $45.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rapid growth of high-risk population, increasing awareness about partner notification programs, rise in the prevalence, increase awareness of syphilis immunoassay diagnostics, and surge in government expenditure on healthcare. Major trends in the forecast period include adoption of innovative technologies, development of rapid point-of-care tests, growing demand for home test kits, advancements in laboratory testing methods, and expansion of the diagnostic laboratory techniques.
Get your syphilis immunoassay diagnostics market report here!
What key factors are fueling the growth of the syphilis immunoassay diagnostics market?
The upward trend in sexually transmitted diseases is anticipated to boost the syphilis immunoassay diagnostics market. Sexually transmitted diseases (STDs), also referred to as sexually transmitted infections (STIs), are infections primarily transmitted via sexual contact, including vaginal, anal, and oral sex. The increasing prevalence of sexually transmitted diseases can be attributed to factors such as decreased condom usage, antibiotic resistance, insufficient sexual education, social and behavioral shifts, stigma, diminished funding for STD programs, and increased travel. Syphilis immunoassay diagnostics play an essential role in identifying and managing sexually transmitted diseases by offering accurate and timely syphilis infection identification, thus enabling the implementation of suitable treatment and preventive strategies. For example, a report by the Terrence Higgins Trust UK documented in June 2024 that the UK Health Security Agency (UKHSA) recorded 401,800 sexually transmitted infections (STIs) in England in 2023, reflecting a 5% increase from the previous year. As a result, the escalating prevalence of sexually transmitted diseases is fueling the growth of the syphilis immunoassay diagnostics market.
How is the global syphilis immunoassay diagnostics market divided into key segments?
The syphilis immunoassay diagnostics market covered in this report is segmented –
1) By Product: Analyzers, Reagents, Kits, Other Products
2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Application: Men, Women
4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users
Subsegments:
1) By Analyzers: Automated Analyzers, Semi-Automated Analyzers, Manual Analyzers
2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents, Chemiluminescent Immunoassay Reagents, Rapid Plasma Reagin Reagents, Treponemal and Non-Treponemal Reagents
3) By Kits: ELISA Kits, Rapid Diagnostic Test Kits, CLIA Kits, Point-Of-Care Test Kits
4) By Other Products: Control and Calibration Materials, Sample Collection Devices, Ancillary Testing Accessories
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16806&type=smp
Who are the key firms paving the way for growth in the syphilis immunoassay diagnostics market?
Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Meril Life Sciences Pvt. Ltd., Randox Laboratories Ltd., SEKISUI Diagnostics, Bloodworks Northwest, LetsGetChecked, Everlywell Inc., ACON Laboratories Inc., Trinity Biotech, Fujirebio, CTK Biotech Inc., bioLytical Laboratories Inc., AdvaCare Pharma, MyBioSource.com, Gold Standard Diagnostics Frankfurt GmbH, Newmarket Biomedical Ltd, InTec PRODUCTS INC., NuGenerex Diagnostics LLC
What emerging trends are influencing the growth of the syphilis immunoassay diagnostics market?
The major players in the syphilis immunoassay diagnostics market are concentrating their efforts on introducing novel solutions like rapid syphilis tests to improve the precision and effectiveness of syphilis detection. These swift syphilis tests are easy-to-use, point-of-care tools allowing for the identification of syphilis antibodies in blood or bodily fluids in just a few minutes, paving the way for prompt diagnosis and early treatment. For instance, in February 2023, a significant advancement was seen when Chembio Diagnostics Inc., an American point-of-care diagnostics firm specializing in infectious diseases, got a CLIA waiver for its DPP HIV-Syphilis System from FDA. The DPP HIV-Syphilis System is a double rapid test, constructed to detect antibodies to HIV 1/2 and Treponema pallidum, responsible for syphilis, at the same time. This quick, spanning 15-minute test, aims at improving diagnosis and treatment, chiefly in stopping the transmission of syphilis from mother to child and reducing the potential risk of HIV among syphilis patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16806
What regions are dominating the syphilis immunoassay diagnostics market growth?
North America was the largest region in the syphilis immunoassay diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syphilis immunoassay diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Cervical Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report
Blood Transfusion Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
